BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17299068)

  • 1. Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.
    Chang HW; Chu TS; Huang HY; Chueh SC; Wu VC; Chen YM; Hsieh BS; Wu KD
    J Clin Endocrinol Metab; 2007 May; 92(5):1863-70. PubMed ID: 17299068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D4 dopamine receptor enhances angiotensin II-stimulated aldosterone secretion through PKC-epsilon and calcium signaling.
    Chang HW; Wu VC; Huang CY; Huang HY; Chen YM; Chu TS; Wu KD; Hsieh BS
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E622-9. PubMed ID: 18171914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of D2 dopamine receptor in adrenal cortical cell proliferation and aldosterone-producing adenoma tumorigenesis.
    Chang HW; Huang CY; Yang SY; Wu VC; Chu TS; Chen YM; Hsieh BS; Wu KD
    J Mol Endocrinol; 2014 Apr; 52(2):87-96. PubMed ID: 24293642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of human dopamine D2 and D4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma.
    Wu KD; Chen YM; Chu TS; Chueh SC; Wu MH; Bor-Shen H
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4460-7. PubMed ID: 11549694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
    Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
    Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
    Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
    J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance.
    Nakamura Y; Yamazaki Y; Tezuka Y; Satoh F; Sasano H
    Tohoku J Exp Med; 2016 Nov; 240(3):183-190. PubMed ID: 27853054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
    Berthon A; Drelon C; Ragazzon B; Boulkroun S; Tissier F; Amar L; Samson-Couterie B; Zennaro MC; Plouin PF; Skah S; Plateroti M; Lefèbvre H; Sahut-Barnola I; Batisse-Lignier M; Assié G; Lefrançois-Martinez AM; Bertherat J; Martinez A; Val P
    Hum Mol Genet; 2014 Feb; 23(4):889-905. PubMed ID: 24087794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
    Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
    Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
    Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion.
    Bird IM; Hanley NA; Word RA; Mathis JM; McCarthy JL; Mason JI; Rainey WE
    Endocrinology; 1993 Oct; 133(4):1555-61. PubMed ID: 8404594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone Stimulates Its Biosynthesis Via a Novel GPER-Mediated Mechanism.
    Caroccia B; Seccia TM; Piazza M; Prisco S; Zanin S; Iacobone M; Lenzini L; Pallafacchina G; Domening O; Poglitsch M; Rizzuto R; Rossi GP
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6316-6324. PubMed ID: 31125081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas.
    Saner-Amigh K; Mayhew BA; Mantero F; Schiavi F; White PC; Rao CV; Rainey WE
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoproteomics Reveals the Wolframin-Calcium Axis as an Important Pathogenic Signaling Node in Primary Aldosteronism.
    Ma L; Yang S; Yang Y; Chen X; Yang J; He Y; Cheng Q; Li J; Kang B; Tang S; Zhang A; Shu X; Li X; Shen H; Jing Y; Song Y; Li Q; Hu J
    Hypertension; 2023 May; 80(5):995-1010. PubMed ID: 36825503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas.
    Di Dalmazi G; Morandi L; Rubin B; Pilon C; Asioli S; Vicennati V; De Leo A; Ambrosi F; Santini D; Pagotto U; Maffeis V; Fassina A; Fallo F
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32844182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA).
    Nakamura Y; Hattangady NG; Ye P; Satoh F; Morimoto R; Ito-Saito T; Sugawara A; Ohba K; Takahashi K; Rainey WE; Sasano H
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):102-8. PubMed ID: 24472523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
    Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.
    Cartier D; Jégou S; Parmentier F; Lihrmann I; Louiset E; Kuhn JM; Bastard C; Plouin PF; Godin M; Vaudry H; Lefebvre H
    Eur J Endocrinol; 2005 Dec; 153(6):939-47. PubMed ID: 16322401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elementary studies on elevated steroidogenic factor-1 expression in aldosterone-producing adenoma.
    Hu D; Ouyang J; Wu Z; Shi T; Wang B; Ma X; Li H; Wang S; Zhang X
    Urol Oncol; 2012; 30(4):457-62. PubMed ID: 20875752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calneuron 1 Increased Ca
    Kobuke K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Ohno H; Itcho K; Yoshii Y; Yoneda M; Hattori N
    Hypertension; 2018 Jan; 71(1):125-133. PubMed ID: 29109191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.